Pharmacy Automation Systems Market size was valued at USD 6,297 Million in 2024 and is anticipated to reach USD 13,379.77 Million by 2032, growing at a CAGR of 9.88% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Pharmacy Automation Market Size 2024
USD 6,297 million
Pharmacy Automation Market, CAGR
9.88%
Pharmacy Automation Market Size 2032
USD 13,379.77 million
Pharmacy Automation Market Insights
Market overview: Demand is increasing due to rising prescription volumes, growing focus on medication accuracy, and the shift toward digital and automated pharmacy workflows across hospitals, clinics, and retail pharmacies, supporting improved efficiency and patient safety.
Markets driver: The dominant product segment is medication dispensing cabinets with a 32.6% share in 2024, driven by their role in reducing medication errors, enhancing workflow speed, and integrating with barcode and electronic health record systems.
Markets trends and competitive analysis: Key players such as Omnicell, ScriptPro, Swisslog, Baxter, and McKesson are expanding AI-enabled robotic dispensing, cloud-based analytics, and modular automation platforms to strengthen scalability and interoperability across multisite healthcare networks.
Markets restraints and regional analysis: High implementation costs and system integration challenges limit adoption in small facilities, while regionally North America leads with 36.8% share in 2024, followed by Europe at 28.4% and Asia-Pacific at 23.6%, reflecting varying levels of healthcare automation maturity.
Pharmacy Automation Market Segmentation Analysis:
By Product
The Pharmacy Automation Systems market by product is led by medication dispensing cabinets, which accounted for 32.6% share in 2024, making them the dominant sub-segment due to their role in improving accuracy, reducing medication errors, and enhancing nursing workflow efficiency. Strong adoption across hospital and clinic pharmacies is driven by growing demand for safer medication management and integration with electronic health records and barcode verification systems. Other key product categories such as robotic dispensing machines, IV pharmacy systems, packaging and labelling machines, carousel storage units, and tablet splitters are gaining traction as healthcare facilities increasingly prioritize automation to improve throughput and inventory control.
For instance, Omnicell’s XT Automated Dispensing Cabinets are deployed in health systems such as UPMC to support closed-loop medication management and barcode verification at the point of care
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Based on application, drug dispensing and packaging emerged as the dominant sub-segment with a 41.3% share in 2024, supported by rising prescription volumes, the need to minimize manual handling, and the push toward standardized, compliant dispensing processes. Pharmacy automation systems deployed in this segment help reduce turnaround time, prevent dispensing errors, and streamline high-volume medication workflows. Drug storage and inventory management applications are also expanding steadily as hospitals and retail chains adopt automated storage and real-time tracking solutions to reduce stock-outs, enhance expiry management, and optimize medication inventory costs across distributed pharmacy networks.
For instance, CVS Health uses large-scale automated dispensing and packaging systems in its mail service and specialty pharmacies to fill and check millions of prescriptions annually with barcode verification and image-based inspection.
By End User
By end user, hospital pharmacies held the largest share at 38.9% in 2024, making them the dominant segment as large healthcare institutions increasingly invest in automation to improve patient safety, enhance medication traceability, and support centralized pharmacy operations. Strong drivers include rising inpatient medication demand, integration of automated dispensing with clinical decision-support systems, and regulatory emphasis on medication administration accuracy. Clinic pharmacies, retail pharmacies, mail-order pharmacies, and pharmaceutical SMEs are also accelerating adoption as they seek to improve workflow efficiency, reduce labour dependency, and support scalable prescription fulfilment models.
Key Growth Drivers
Rising Need for Error Reduction and Workflow Efficiency in Medication Management
The Pharmacy Automation Systems market is experiencing strong growth as healthcare providers increasingly prioritize patient safety, medication accuracy, and operational efficiency. Automation technologies significantly reduce human error in dispensing, packaging, and inventory management, which is critical as prescription volumes rise and hospital workflow complexity increases. Automated dispensing and verification systems enhance dosage accuracy, reduce adverse drug events, and support compliance with medication safety regulations. At the same time, healthcare institutions benefit from faster turnaround times, optimized staffing, and improved pharmacy productivity. Integration with electronic health records, barcode scanning, and clinical decision-support platforms further strengthens medication traceability and accountability. As hospitals and retail pharmacies move toward digitized and data-driven medication workflows, the role of automation expands from a support function to a strategic infrastructure investment, accelerating adoption across both developed and emerging healthcare markets.
For instance, the Institute of Medicine has estimated that medication errors harm at least 1.5 million people annually in the U.S., prompting hospitals to adopt automated dispensing and verification technologies to improve safety.
Growing Demand for Centralized and Decentralized Pharmacy Operations
A major growth driver for the Pharmacy Automation Systems market is the increasing adoption of centralized and decentralized pharmacy models to improve medication distribution efficiency across healthcare networks. Centralized compounding, packaging, and inventory hubs rely on automation to manage high-volume operations, reduce labour dependency, and support standardized medication preparation. At the same time, decentralized automated dispensing units in patient care areas enable faster medication access and reduce pharmacist workload. This dual-model approach improves cost control, strengthens supply-chain transparency, and enhances medication traceability across hospitals, clinics, and retail chains. The expansion of outpatient care, specialty pharmacies, and mail-order prescription services further reinforces the need for scalable automation platforms. As healthcare systems modernize infrastructure to support multi-location operations and tele-pharmacy services, automation becomes essential for maintaining consistency, efficiency, and service quality across distributed pharmacy environments.
For instance, CVS Health and Walgreens operate large, automated central-fill facilities that process and package high prescription volumes for multiple retail locations, helping standardize dispensing and reduce in-store workload.
Technological Advancements and Integration with Digital Health Ecosystems
Technological innovation is a key driver accelerating market expansion, as pharmacy automation solutions increasingly integrate with digital health ecosystems, analytics platforms, and cloud-based management systems. AI-enabled robotic dispensing, automated storage, and smart inventory solutions support predictive supply planning and real-time medication tracking. Advanced IV compounding systems and robotic filling technologies are improving sterility assurance and production precision in hospital pharmacies. Meanwhile, interoperability with hospital information systems, prescription management software, and e-prescribing platforms enhances workflow coordination and data accuracy. Automation vendors are also introducing modular, configurable systems to meet varied pharmacy footprints and budget levels. These advancements not only improve clinical and operational outcomes but also strengthen return on investment for healthcare providers. As digital transformation accelerates across healthcare, technology-enabled pharmacy automation is increasingly viewed as a strategic enabler of modern, data-driven medication management.
Key Trends & Opportunities
Expansion of Retail, Specialty, and Mail-Order Pharmacy Automation
A major trend shaping the Pharmacy Automation Systems market is the rapid expansion of automation adoption in retail, specialty, and mail-order pharmacy environments. Rising chronic disease prevalence, subscription-based medication programs, and home-delivery models are increasing prescription handling complexity and driving demand for high-throughput automated dispensing and packaging systems. Retail chains are investing in smart storage, automated counting, and workflow optimization tools to reduce wait times and improve service consistency. Specialty pharmacies benefit from automation-enabled traceability and cold-chain monitoring, particularly for high-value biologics and oncology medications. Mail-order facilities increasingly depend on robotic dispensing, automated labelling, and centralized inventory analytics to manage large-scale fulfillment operations. This shift creates significant opportunities for technology providers offering scalable, cloud-integrated, and regulatory-compliant automation platforms tailored to evolving pharmacy retail ecosystems.
For instance, many U.S. community pharmacies use automated tablet counters such as the Kirby Lester line (now part of Capsa Healthcare) to improve accuracy and speed in daily dispensing while integrating with pharmacy management systems.
Adoption of Data-Driven and AI-Enabled Pharmacy Operations
Another key trend and opportunity lies in the transition toward analytics-driven and AI-enabled pharmacy automation systems that support smarter decision-making and operational optimization. Intelligent inventory forecasting, automated replenishment, and predictive maintenance tools help reduce waste, prevent stock-outs, and improve medication availability. AI-assisted verification and image-recognition technologies are enhancing quality control in dispensing and compounding processes. Cloud connectivity enables real-time performance monitoring across multi-site pharmacy networks, supporting benchmarking and centralized oversight. These capabilities create value beyond basic automation by enabling continuous process improvement and strategic resource planning. As healthcare institutions seek greater transparency, efficiency, and data integration, vendors offering AI-driven workflow intelligence, interoperability features, and automation-as-a-service business models are well-positioned to capture emerging market opportunities.
For instance, Omnicell’s cloud-based medication management platform uses analytics to optimize cabinet stocking and refills, helping health systems reduce inventory carrying costs and out-of-stock events.
Key Challenges
High Implementation Costs and Infrastructure Complexity
Despite strong growth potential, the Pharmacy Automation Systems market faces challenges related to high capital investment requirements and infrastructure complexity, particularly for hospitals and pharmacies in cost-sensitive environments. Large-scale automation deployments require significant upfront spending on hardware, software integration, facility modifications, and staff training. Smaller clinics, independent pharmacies, and low-resource healthcare settings may struggle to justify investment without clear financial returns. Additionally, integrating automation with legacy IT systems, EHR platforms, and supply-chain software can create technical barriers and extend implementation timelines. Ongoing maintenance, calibration, and cybersecurity management further add to ownership costs. These financial and operational constraints can slow adoption, especially in emerging markets and small-to-mid-size pharmacy environments.
Workforce Adaptation, Regulatory Compliance, and Operational Risks
Another major challenge involves workforce adaptation, regulatory compliance, and operational risk management associated with automation deployment. Transitioning from manual to automated workflows requires cultural change, specialized training, and adjustments in clinical responsibility distribution between pharmacists and technicians. Any system malfunction, programming error, or improper configuration can introduce new types of operational risks, including medication delays or process bottlenecks. Strict regulatory and safety standards governing sterile compounding, medication handling, and data security also require continuous system validation and audit readiness. Pharmacies must balance automation benefits with human oversight to ensure safety, accountability, and ethical use of technology. These organizational and regulatory complexities may slow implementation maturity and require structured change-management strategies to achieve successful, sustainable automation adoption.
Regional Analysis
North America
North America held the largest share of the Pharmacy Automation Systems market in 2024, accounting for 36.8% of global revenue, driven by advanced healthcare infrastructure, strong hospital automation investments, and widespread adoption of electronic prescribing and medication safety standards. High prescription volumes, workforce shortages, and regulatory emphasis on error prevention are accelerating deployment of automated dispensing, packaging, and inventory systems across hospitals, retail chains, and mail-order pharmacies. The United States leads regional growth due to mature digital health ecosystems and strong R&D activity, while Canada is expanding adoption through modernization initiatives in public and private healthcare networks.
Europe
Europe accounted for 28.4% share of the Pharmacy Automation Systems market in 2024, supported by robust pharmaceutical regulation, strong patient safety frameworks, and increasing automation integration across hospital and community pharmacy settings. Countries such as Germany, the United Kingdom, France, and the Nordics are leading adoption through centralized medication management programs and technology-enabled hospital workflows. Growth is further reinforced by the expansion of outpatient care, aging populations, and rising demand for efficient prescription fulfillment. Investment focus remains on robotic dispensing, automated storage, and sterile compounding solutions, alongside interoperability with national healthcare information systems to enhance operational transparency.
Asia-Pacific
Asia-Pacific captured 23.6% share of the Pharmacy Automation Systems market in 2024 and represents the fastest-growing region, driven by rapid healthcare digitalization, rising hospital capacity, and expanding retail and mail-order pharmacy networks. Countries such as China, Japan, India, South Korea, and Australia are increasingly adopting automated dispensing and inventory technologies to manage high patient volumes and address medication safety challenges. Government investment in smart hospital initiatives and pharmaceutical supply-chain modernization is also accelerating demand. Growing chronic disease prevalence and urbanization are encouraging scalable, high-throughput automation deployments across both public and private healthcare settings across the region.
Latin America
Latin America accounted for 6.5% share of the Pharmacy Automation Systems market in 2024, with growth supported by gradual modernization of hospital pharmacies, rising adoption of digital prescription systems, and increasing investments from private healthcare providers. Brazil, Mexico, Chile, and Colombia are leading deployments, particularly in large urban hospitals and emerging retail pharmacy chains seeking workflow efficiency and inventory control. Although budget constraints limit large-scale implementations, pilot programs in automated dispensing, barcode verification, and storage automation are expanding steadily. Growing awareness of medication error reduction and supply-chain transparency is expected to support sustained market penetration across the region.
Middle East & Africa
The Middle East & Africa region held a 4.7% share of the Pharmacy Automation Systems market in 2024, characterized by selective but rapidly increasing adoption in technologically advanced healthcare hubs such as the UAE, Saudi Arabia, and Qatar. Investments in smart hospitals, specialty care centers, and digital health infrastructure are driving demand for automated dispensing, IV compounding, and centralized pharmacy systems. In Africa, adoption remains limited but is gradually expanding in private hospital groups and international healthcare networks. Increasing focus on patient safety, workforce optimization, and medication traceability is expected to create long-term growth opportunities across the region.
Pharmacy Automation Market Segmentations:
By Product
Medication Dispensing Cabinets
Packaging & Labelling Machines
IV Pharmacy
Robotic Dispensing Machines
Carousel Storage
Tablet Splitters
By Application
Drug Dispensing & Packaging
Drug Storage
Inventory Management
By End User
Hospital Pharmacies
Clinic Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Pharmaceutical SME’s
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
The Pharmacy Automation Systems market is characterized by the presence of several established global players that focus on technology innovation, workflow integration, and strategic partnerships to strengthen their competitive positioning. Companies such as Omnicell Inc., ScriptPro LLC, Swisslog Holdings AG, Baxter International Inc., Cerner Corporation, AmerisourceBergen Corporation, CareFusion Corporation, Kirby Lester LLC, Talyst LLC, and McKesson Corporation play a dominant role through extensive product portfolios spanning automated dispensing cabinets, robotic dispensing systems, packaging and labeling solutions, IV compounding technologies, and smart inventory management platforms. Market competition is driven by advancements in AI-enabled automation, interoperability with hospital information systems, and modular, scalable product architectures tailored for multisite healthcare environments. Vendors are increasingly investing in cloud-based analytics, remote monitoring, and cybersecurity capabilities to enhance system reliability and value proposition. Strategic mergers, regional expansion, and long-term hospital network contracts further support market consolidation, while emerging players compete by offering niche automation solutions and cost-effective deployment models.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In October 2025, MedPal AI plc completed the acquisition of assets from Universal Pharmacy Ltd, expanding its assets and capabilities which can support automated pharmacy services.
In September 2025, BD (Becton, Dickinson and Company) announced a pharmacy automation partnership with Henry Ford Health to integrate the BD Rowa™ Vmax robotic automation solution into Henry Ford Health’s pharmacy operations to enhance medication storage and prescription retrieval processes.
In April 2025, VusionGroup partnered with leading pharmacy chain Dr. Max for advanced store digitalization across Europe, enhancing pharmacy automation and digital in-store workflows.
Report Coverage
The research report offers an in-depth analysis based on Product, Application, End-User andGeography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The market will witness increasing adoption of automation across hospital, retail, and mail-order pharmacies to improve accuracy, workflow efficiency, and medication safety.
Vendors will integrate AI, analytics, and cloud-based platforms to enable smarter dispensing, predictive inventory planning, and real-time operational monitoring.
Pharmacy automation will expand further into decentralized care settings, outpatient facilities, and specialty pharmacies to support high-volume and complex prescription handling.
Robotic dispensing and IV compounding technologies will gain stronger traction as healthcare providers prioritize sterility, precision, and standardized medication preparation.
Interoperability with electronic health records, e-prescribing systems, and digital health platforms will continue to strengthen data connectivity and traceability.
Workforce shortages in pharmacy operations will accelerate investment in automated workflows to reduce manual dependency and optimize staffing efficiency.
Cybersecurity, system reliability, and regulatory compliance will become critical focus areas as automation systems become more network-integrated.
Emerging markets will increasingly adopt automation as healthcare infrastructure modernizes and digital transformation initiatives expand.
Vendors will emphasize modular, scalable, and cost-efficient automation models to support small and mid-size healthcare facilities.
The market will see continued consolidation through partnerships, technology collaborations, and long-term service agreements among leading industry players.
Table of Contents (The complete Toc, LoF and LoT are available in the sample report)
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Pharmacy Automation Systems Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Product
6.1. Medication Dispensing Cabinets
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Packaging & Labelling Machines
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity
6.3. IV Pharmacy
6.3.1. Market Trends
6.3.2. Market Forecast
6.3.3. Revenue Share
6.3.4. Revenue Growth Opportunity
6.4. Robotic Dispensing Machines
6.4.1. Market Trends
6.4.2. Market Forecast
6.4.3. Revenue Share
6.4.4. Revenue Growth Opportunity
6.5. Carousel Storage
6.5.1. Market Trends
6.5.2. Market Forecast
6.5.3. Revenue Share
6.5.4. Revenue Growth Opportunity
6.6. Tablet Splitters
6.6.1. Market Trends
6.6.2. Market Forecast
6.6.3. Revenue Share
6.6.4. Revenue Growth Opportunity 7. Market Breakup by Application
7.1. Drug Dispensing & Packaging
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Drug Storage
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity
7.3. Inventory Management
7.3.1. Market Trends
7.3.2. Market Forecast
7.3.3. Revenue Share
7.3.4. Revenue Growth Opportunity 8. Market Breakup by End User
8.1. Hospital Pharmacies
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Clinic Pharmacies
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity
8.3. Retail Pharmacies
8.3.1. Market Trends
8.3.2. Market Forecast
8.3.3. Revenue Share
8.3.4. Revenue Growth Opportunity
8.4. Mail Order Pharmacies
8.4.1. Market Trends
8.4.2. Market Forecast
8.4.3. Revenue Share
8.4.4. Revenue Growth Opportunity
8.5. Pharmaceutical SME’s
8.5.1. Market Trends
8.5.2. Market Forecast
8.5.3. Revenue Share
8.5.4. Revenue Growth Opportunity 9. Market Breakup by Region
9.1. North America
9.1.1. United States
9.1.1.1. Market Trends
9.1.1.2. Market Forecast
9.1.2. Canada
9.1.2.1. Market Trends
9.1.2.2. Market Forecast
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia
9.2.6. Indonesia
9.2.7. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Others
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Others
9.5. Middle East and Africa
9.5.1. Market Trends
9.5.2. Market Breakup by Country
9.5.3. Market Forecast 10. SWOT Analysis
10.1. Overview
10.2. Strengths
10.3. Weaknesses
10.4. Opportunities
10.5. Threats 11. Value Chain Analysis 12. Porter’s Five Forces Analysis
12.1. Overview
12.2. Bargaining Power of Buyers
12.3. Bargaining Power of Suppliers
12.4. Degree of Competition
12.5. Threat of New Entrants
12.6. Threat of Substitutes 13. Price Analysis 14. Competitive Landscape
14.1. Market Structure
14.2. Key Players
14.3. Profiles of Key Players
14.3.1. ScriptPro LLC
14.3.2. Cerner Corporation
14.3.3. Omnicell Inc.
14.3.4. Talyst, LLC.
14.3.5. Baxter International Inc.
14.3.6. Kirby Lester LLC
14.3.7. Swisslog Holdings AG
14.3.8. CareFusion Corporation
14.3.9. AmerisourceBergen Corporation
14.3.10. McKesson Corporation 15. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Question:
What is the current market size for the Pharmacy Automation Systems Market, and what is its projected size in 2032?
The Pharmacy Automation Systems Market is valued at USD 6,297 Million in 2024 and is projected to reach USD 13,379.77 Million by 2032, reflecting strong growth across healthcare automation investments in the Pharmacy Automation Systems Market.
At what Compound Annual Growth Rate is the Pharmacy Automation Systems Market projected to grow between 2024 and 2032?
The Pharmacy Automation Systems Market is projected to grow at a CAGR of 9.88% between 2024 and 2032, driven by increasing demand for efficient dispensing and medication management automation in the Pharmacy Automation Systems Market.
Which Pharmacy Automation Systems Market segment held the largest share in 2024?
The medication dispensing cabinets segment held the largest share in 2024 with 32.6% of the Pharmacy Automation Systems Market, supported by its role in reducing errors and improving workflow efficiency in the Pharmacy Automation Systems Market.
What are the primary factors fueling the growth of the Pharmacy Automation Systems Market?
Growth in the Pharmacy Automation Systems Market is fueled by rising prescription volumes, increasing focus on patient safety, workflow automation needs, and integration of digital and robotic dispensing technologies in the Pharmacy Automation Systems Market.
Who are the leading companies in the Pharmacy Automation Systems Market?
Leading companies in the Pharmacy Automation Systems Market include Omnicell Inc., ScriptPro LLC, Swisslog Holdings AG, Baxter International Inc., Cerner Corporation, AmerisourceBergen Corporation, CareFusion Corporation, Kirby Lester LLC, Talyst LLC, and McKesson Corporation in the Pharmacy Automation Systems Market.
Which region commanded the largest share of the Pharmacy Automation Systems Market in 2024?
North America commanded the largest share of the Pharmacy Automation Systems Market in 2024 with 36.8%, driven by advanced healthcare infrastructure and high adoption of automation technologies in the Pharmacy Automation Systems Market.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The Europe Cardiovascular Devices Market size was valued at USD 11,331.07 MN in 2021 and reached USD 14,497.23 MN in 2025. It is anticipated to reach USD 23,398.08 MN by 2032, growing at a CAGR of 5.97% during the forecast period.
The North America Over-the-Counter (OTC) Drugs Market size was valued at USD 72,391.68 MN in 2021 and reached USD 93,061.46 MN in 2025. It is anticipated to reach USD 155,694.86 MN by 2032, growing at a CAGR of 6.49% during the forecast period.
The North America Specialty Pharmaceuticals Market size was valued at USD 67,838.21 MN in 2021 and reached USD 109,086.83 MN in 2025. It is anticipated to reach USD 260,733.67 MN by 2032, growing at a CAGR of 11.03% during the forecast period.
The North America Contract Development & Manufacturing (CDMO) Market size was valued at USD 78,825.77 MN in 2021 and reached USD 103,977.23 MN in 2025. It is anticipated to reach USD 181,244.06 MN by 2032, growing at a CAGR of 7.00% during the forecast period.
The Europe Prescription Drugs Market size was valued at USD 294,866.12 MN in 2021 and reached USD 365,960.68 MN in 2025. It is anticipated to reach USD 553,623.53 MN by 2032, growing at a CAGR of 5.13% during the forecast period.
Cell therapy consumables Market was valued at USD 3439 million in 2024 and is anticipated to reach USD 7533.31 million by 2032, growing at a CAGR of 10.3% during the forecast period.
The Asia Pacific RNA-based Therapeutics Market size was valued at USD 1,025.76 MN in 2021 and reached USD 1,749.49 MN in 2025. It is anticipated to reach USD 4,685.07 MN by 2032, growing at a CAGR of 12.57% during the forecast period.
The Crohn's Disease Treatment Market size was valued at USD 11,920 million in 2024 and is anticipated to reach USD 15,478.65 million by 2032, growing at a CAGR of 3.32% during the forecast period.
The Asia Pacific Monoclonal Antibodies Market size was valued at USD 40,541.17 MN in 2021 and reached USD 64,255.32 MN in 2025. It is anticipated to reach USD 149,792.56 MN by 2032, growing at a CAGR of 10.70% during the forecast period.
The Africa Orphan Drugs Market size was valued at USD 792.75 MN in 2021 and reached USD 1,258.16 MN in 2025. It is anticipated to reach USD 2,826.51 MN by 2032, growing at a CAGR of 6.30% during the forecast period.
The Middle East Vaccines Market size was valued at USD 873.98 MN in 2021 and reached USD 1,325.11 MN in 2025. It is anticipated to reach USD 2,813.55 MN by 2032, growing at a CAGR of 9.44% during the forecast period.
The Africa Biosimilars Market size was valued at USD 126.63 MN in 2021 and reached USD 200.98 MN in 2025. It is anticipated to reach USD 451.50 MN by 2032, growing at a CAGR of 7.80% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
